Article

A severe case of cutaneous squamous cell carcinoma keratoacanthoma type in a 55-year-old man


 

Cutaneous squamous cell carcinoma (SCC) is the second most common nonmelanoma skin cancer. The clinical features of SCC typically include scaly, crusted, nonhealing, ulcerative lesions in sun-exposed areas of the body. We present here the interesting case of a patient who was diagnosed with extremely severe SCC, keratoacanthoma-type (KA; SCC-KA type) with multiple annular, crusted, papular lesions (8-20 mm) on the dorsal aspect of his hands and forearms. The patient was successfully treated with cetuximab over 78 days, with complete resolution.

*Click on the link to the left for a PDF of the full article.

Recommended Reading

New data improve characterization of pediatric melanoma
MDedge Hematology and Oncology
Agencies continue push for indoor tanning regulations
MDedge Hematology and Oncology
Ipilimumab plus surgery boosted advanced melanoma survival
MDedge Hematology and Oncology
One in four melanoma patients shun sunscreen
MDedge Hematology and Oncology
Melanoma increases in adolescents
MDedge Hematology and Oncology
Therapeutic combos make inroads in advanced melanoma
MDedge Hematology and Oncology
FDA advisory panel nixes approval of drug-device for liver metastases
MDedge Hematology and Oncology
'Slow Mohs' advised for lentigo maligna
MDedge Hematology and Oncology
Dual immunotherapy scores rapid response in metastatic melanoma
MDedge Hematology and Oncology
FDA approves two more drugs for advanced melanoma
MDedge Hematology and Oncology